Endovascular Therapy for Stroke Due to Basilar-Artery Occlusion
- PMID: 34010530
- DOI: 10.1056/NEJMoa2030297
Endovascular Therapy for Stroke Due to Basilar-Artery Occlusion
Abstract
Background: The effectiveness of endovascular therapy in patients with stroke caused by basilar-artery occlusion has not been well studied.
Methods: We randomly assigned patients within 6 hours after the estimated time of onset of a stroke due to basilar-artery occlusion, in a 1:1 ratio, to receive endovascular therapy or standard medical care. The primary outcome was a favorable functional outcome, defined as a score of 0 to 3 on the modified Rankin scale (range, 0 to 6, with 0 indicating no disability, 3 indicating moderate disability, and 6 indicating death) at 90 days. The primary safety outcomes were symptomatic intracranial hemorrhage within 3 days after the initiation of treatment and mortality at 90 days.
Results: A total of 300 patients were enrolled (154 in the endovascular therapy group and 146 in the medical care group). Intravenous thrombolysis was used in 78.6% of the patients in the endovascular group and in 79.5% of those in the medical group. Endovascular treatment was initiated at a median of 4.4 hours after stroke onset. A favorable functional outcome occurred in 68 of 154 patients (44.2%) in the endovascular group and 55 of 146 patients (37.7%) in the medical care group (risk ratio, 1.18; 95% confidence interval [CI], 0.92 to 1.50). Symptomatic intracranial hemorrhage occurred in 4.5% of the patients after endovascular therapy and in 0.7% of those after medical therapy (risk ratio, 6.9; 95% CI, 0.9 to 53.0); mortality at 90 days was 38.3% and 43.2%, respectively (risk ratio, 0.87; 95% CI, 0.68 to 1.12).
Conclusions: Among patients with stroke from basilar-artery occlusion, endovascular therapy and medical therapy did not differ significantly with respect to a favorable functional outcome, but, as reflected by the wide confidence interval for the primary outcome, the results of this trial may not exclude a substantial benefit of endovascular therapy. Larger trials are needed to determine the efficacy and safety of endovascular therapy for basilar-artery occlusion. (Funded by the Dutch Heart Foundation and others; BASICS ClinicalTrials.gov number, NCT01717755; Netherlands Trial Register number, NL2500.).
Copyright © 2021 Massachusetts Medical Society.
Comment in
-
Endovascular Therapy for Basilar-Artery Occlusion - Still Waiting for Answers.N Engl J Med. 2021 May 20;384(20):1954-1955. doi: 10.1056/NEJMe2104814. N Engl J Med. 2021. PMID: 34010535 No abstract available.
-
Trial of Endovascular Treatment of Basilar-Artery Occlusion.N Engl J Med. 2021 Sep 2;385(10):958. doi: 10.1056/NEJMc2109962. N Engl J Med. 2021. PMID: 34469657 No abstract available.
-
Trial of Endovascular Treatment of Basilar-Artery Occlusion.N Engl J Med. 2021 Sep 2;385(10):958-959. doi: 10.1056/NEJMc2109962. N Engl J Med. 2021. PMID: 34469658 No abstract available.
-
Trial of Endovascular Treatment of Basilar-Artery Occlusion.N Engl J Med. 2021 Sep 2;385(10):959. doi: 10.1056/NEJMc2109962. N Engl J Med. 2021. PMID: 34469659 No abstract available.
Similar articles
-
Trial of Endovascular Treatment of Acute Basilar-Artery Occlusion.N Engl J Med. 2022 Oct 13;387(15):1361-1372. doi: 10.1056/NEJMoa2206317. N Engl J Med. 2022. PMID: 36239644 Clinical Trial.
-
Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion.N Engl J Med. 2022 Oct 13;387(15):1373-1384. doi: 10.1056/NEJMoa2207576. N Engl J Med. 2022. PMID: 36239645 Clinical Trial.
-
Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging.N Engl J Med. 2018 Feb 22;378(8):708-718. doi: 10.1056/NEJMoa1713973. Epub 2018 Jan 24. N Engl J Med. 2018. PMID: 29364767 Free PMC article. Clinical Trial.
-
Endovascular thrombectomy with versus without intravenous thrombolysis in patients with acute basilar artery occlusion: a systematic review and meta-analysis.J Neurol. 2024 Jun;271(6):3039-3049. doi: 10.1007/s00415-024-12353-w. Epub 2024 Apr 10. J Neurol. 2024. PMID: 38597945 Review.
-
Endovascular thrombectomy for basilar artery occlusion: translating research findings into clinical practice.Lancet Neurol. 2023 Apr;22(4):330-337. doi: 10.1016/S1474-4422(22)00483-5. Epub 2023 Feb 10. Lancet Neurol. 2023. PMID: 36780915 Review.
Cited by
-
Efficacy and safety of thrombectomy with or without intravenous thrombolysis in the treatment of acute basilar artery occlusion ischemic stroke: an updated systematic review and meta-analysis.Front Neurol. 2024 Oct 24;15:1433158. doi: 10.3389/fneur.2024.1433158. eCollection 2024. Front Neurol. 2024. PMID: 39512275 Free PMC article.
-
Endovascular treatment versus medical management for basilar artery occlusion with low-to-moderate symptoms (National Institutes of Health Stroke Scale < 10).Eur Stroke J. 2024 Oct 13:23969873241290442. doi: 10.1177/23969873241290442. Online ahead of print. Eur Stroke J. 2024. PMID: 39397363 Free PMC article.
-
Radiographic predictors of neurologic outcomes in patients with basilar artery occlusion: A single-center experience.Interv Neuroradiol. 2024 Sep 23:15910199241285581. doi: 10.1177/15910199241285581. Online ahead of print. Interv Neuroradiol. 2024. PMID: 39311038 Free PMC article.
-
Selective intra-arterial hypothermia combined with endovascular thrombectomy for large vessel occlusion: A systematic review and meta-analysis.Interv Neuroradiol. 2024 Sep 19:15910199241285157. doi: 10.1177/15910199241285157. Online ahead of print. Interv Neuroradiol. 2024. PMID: 39295472 Free PMC article. Review.
-
What You Always Wanted to Know about Endovascular Therapy in Acute Ischemic Stroke but Never Dared to Ask: A Comprehensive Review.Rev Cardiovasc Med. 2022 Oct 11;23(10):340. doi: 10.31083/j.rcm2310340. eCollection 2022 Oct. Rev Cardiovasc Med. 2022. PMID: 39077121 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical